Clinical Trial Update: Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating neutrophil gelatinase-associated lipocalin (NGAL) in relation to vascular calcification in maintenance hemodialysis patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Chronic Kidney Disease-mineral and Bone Disorder
• Vascular Calcification

Drugs mentioned

• Neutrophil gelatinase-associated lipocalin (NGAL)

Snippet

Sponsor: Xiaoyan Jia | Conditions: Chronic Kidney Disease-Mineral and Bone Disorder | Phase 4 | Status: UNKNOWN